Top of this page
Skip navigation, go straight to the content

Our Company

Disease Areas

Our Science

UCB Worldwide

 Search

Our Products

Newsroom

Patients

Investors

FOLLOW US ON
© 2007 – 2019 UCB S.A., Belgium. All rights reserved.
Newsroom • Press Releases

Search Press releases


UCB builds on its R&D footprint to form a research satellite facility within King’s College London15 Feb 2019

UCB builds on its R&D footprint to form …

Read more
UCB and Epilepsy Society announce pioneering UK Genomics R&D collaboration 10 Feb 2019

UCB and Epilepsy Society announce pioneering UK Genomics R& …

Read more
Transparency notification BlackRock, Inc.30 Jan 2019

Transparency notification BlackRock, Inc.

Read more
Transparency notification BlackRock, Inc.25 Jan 2019

Transparency notification BlackRock, Inc.

Read more
UCB and Amgen Receive Positive Vote From FDA Advisory Committee In Favor of Approval For EVENITY™ (Romosozumab) 16 Jan 2019

UCB and Amgen Receive Positive Vote From FDA Advisory Committee …

Read more
EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of Osteoporosis In Patients at High Risk of Fracture08 Jan 2019

EVENITY® (romosozumab) Receives Approval In Japan for the Treatment of …

Read more


Stay up-to-date on the latest news and information from UCB